- Home
- PAVM vs MTEM Comparison
PAVM vs MTEM Comparison
Compare PAVM & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- MTEM
- Stock Information
- Founded
- PAVM 2014
- MTEM 2001
- Country
- PAVM United States
- MTEM United States
- Employees
- PAVM N/A
- MTEM N/A
- Industry
- PAVM Medical/Dental Instruments
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAVM Health Care
- MTEM Health Care
- Exchange
- PAVM Nasdaq
- MTEM Nasdaq
- Market Cap
- PAVM 10.2M
- MTEM 9.7M
- IPO Year
- PAVM 2016
- MTEM N/A
- Fundamental
- Price
- PAVM $1.01
- MTEM $0.38
- Analyst Decision
- PAVM Strong Buy
- MTEM
- Analyst Count
- PAVM 1
- MTEM 0
- Target Price
- PAVM $21.00
- MTEM N/A
- AVG Volume (30 Days)
- PAVM 52.5K
- MTEM 17.8M
- Earning Date
- PAVM 11-13-2024
- MTEM 11-26-2024
- Dividend Yield
- PAVM N/A
- MTEM N/A
- EPS Growth
- PAVM N/A
- MTEM N/A
- EPS
- PAVM 0.53
- MTEM N/A
- Revenue
- PAVM $4,034,000.00
- MTEM $25,470,000.00
- Revenue This Year
- PAVM $70.80
- MTEM N/A
- Revenue Next Year
- PAVM $298.02
- MTEM N/A
- P/E Ratio
- PAVM $1.95
- MTEM N/A
- Revenue Growth
- PAVM 166.27
- MTEM N/A
- 52 Week Low
- PAVM $0.60
- MTEM $0.30
- 52 Week High
- PAVM $4.88
- MTEM $5.37
- Technical
- Relative Strength Index (RSI)
- PAVM 43.42
- MTEM 38.94
- Support Level
- PAVM $0.99
- MTEM $0.32
- Resistance Level
- PAVM $1.10
- MTEM $0.62
- Average True Range (ATR)
- PAVM 0.09
- MTEM 0.11
- MACD
- PAVM -0.00
- MTEM 0.03
- Stochastic Oscillator
- PAVM 9.09
- MTEM 7.41
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.